Mangoceuticals Inc
NASDAQ:MGRX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
M
|
Mangoceuticals Inc
NASDAQ:MGRX
|
US |
|
Pyxis Finvest Ltd
BSE:534109
|
IN |
|
Matahari Department Store Tbk PT
IDX:LPPF
|
ID |
|
Global Arena Holding Inc
OTC:GAHC
|
US |
|
Aydem Yenilenebilir Enerji AS
IST:AYDEM.E
|
TR |
|
H
|
Hyunwoo Industrial Co Ltd
KOSDAQ:092300
|
KR |
|
Accolade Inc
NASDAQ:ACCD
|
US |
|
Resource Alam Indonesia Tbk PT
IDX:KKGI
|
ID |
|
Aksh Optifibre Ltd
NSE:AKSHOPTFBR
|
IN |
|
American Electric Power Company Inc
NASDAQ:AEP
|
US |
|
F
|
Fincera Inc
OTC:YUANF
|
US |
|
F
|
Fortune Ng Fung Food Hebei Co Ltd
SSE:600965
|
CN |
|
M
|
Minera Valparaiso SA
SGO:MINERA
|
CL |
|
Bombardier Inc
TSX:BBD.B
|
CA |
|
Lang & Schwarz AG
XETRA:LUS1
|
DE |
Mangoceuticals Inc
Mangoceuticals, Inc. engages in developing, marketing, and selling men’s wellness products and services via a telemedicine platform. The company is headquartered in Dallas, Texas. The company went IPO on 2023-03-21. The firm has developed and is in the process of preparing to commercially market a brand of erectile dysfunction (ED) product under the brand name Mango. The Company’s Mango ED product includes the ingredients, such as Tadalafil (10 milligrams (mg)), Oxytocin (100 International units (IU)) and L-Arginine (50mg), and Tadalafil (20mg), Oxytocin (100IU) and L-Arginine (50mg). The firm connects consumers to licensed healthcare professionals through its Website at www.MangoRX.com for the provision of care via telehealth through its customer portal and provides access for customers to a licensed pharmacy for online fulfillment and distribution of certain medications that may be prescribed as part of telehealth consultations, including its Mango ED product.
Mangoceuticals, Inc. engages in developing, marketing, and selling men’s wellness products and services via a telemedicine platform. The company is headquartered in Dallas, Texas. The company went IPO on 2023-03-21. The firm has developed and is in the process of preparing to commercially market a brand of erectile dysfunction (ED) product under the brand name Mango. The Company’s Mango ED product includes the ingredients, such as Tadalafil (10 milligrams (mg)), Oxytocin (100 International units (IU)) and L-Arginine (50mg), and Tadalafil (20mg), Oxytocin (100IU) and L-Arginine (50mg). The firm connects consumers to licensed healthcare professionals through its Website at www.MangoRX.com for the provision of care via telehealth through its customer portal and provides access for customers to a licensed pharmacy for online fulfillment and distribution of certain medications that may be prescribed as part of telehealth consultations, including its Mango ED product.
